We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Momenta Gains Patent on Copaxone But Teva Denies Generic is Close
Momenta Gains Patent on Copaxone But Teva Denies Generic is Close
February 15, 2011
Momenta Pharmaceuticals has been granted a patent for a method of developing its generic version of Copaxone, but Teva Pharmaceutical Industries maintains that its blockbuster multiple sclerosis drug is not facing imminent competition.